Company Filing History:
5 out of 22 
1 out of 832,718 Years Active: 2009-2016
Title: Paul Harden: Innovator in Cancer Treatment
Introduction
Paul Harden is a notable inventor based in Brentwood, CA (US), recognized for his contributions to the field of cancer treatment through innovative technologies. With a total of six patents to his name, Harden has made significant strides in the development of therapeutic applications using chimeric adenoviruses.
Latest Patents
Harden's latest patents focus on chimeric adenoviruses designed for use in cancer treatment. These oncolytic adenoviruses have therapeutic applications that are groundbreaking. The inventions provide recombinant chimeric adenoviruses and methods for their production. The chimeric adenoviruses comprise nucleic acid sequences derived from adenoviral serotypes classified within subgroups B through F, demonstrating an enhanced therapeutic index.
Career Highlights
Throughout his career, Paul Harden has worked with various organizations, including Psioxus Therapeutics Limited. His work has been pivotal in advancing the understanding and application of adenoviral therapies in oncology.
Collaborations
Harden has collaborated with notable professionals in the field, including Terry Hermiston and Irene Kuhn. These partnerships have contributed to the success and development of his innovative projects.
Conclusion
Paul Harden's work in the field of cancer treatment through chimeric adenoviruses showcases his dedication to innovation and improving therapeutic options for patients. His contributions are significant in the ongoing fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.